Hypertrophic Cardiomyopathy is a genetic disease which causes the muscle of the heart to thicken. Left untreated, it can lead to heart failure, and it’s quite common. But the therapies we have available at the moment treat only the symptoms and don’t alter underlying disease course. Now new research from Harvard University, published in Science Translational Medicine, has identified the molecular clockwork that actually causes the condition, and they’re testing a new drug that may help to stop it. Adam Murphy spoke to Chris Toepfer to hear how...
Comments
Thanks Adam, this is an
Thanks Adam, this is an interesting piece. What's the best to follow up and stay informed on the progress of this particular research?
Add a comment